BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL - DE 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:400-500
Total Number of Projects:700-800
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2021-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 8
As coordinator: 0
As participant: 8
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 14.828.927 731.788 3
2020 0 3.969.583 505.577 1
2019 0 24.990.269 1.110.181 3
2018 0 6.097.875 342.875 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V3
MEDIZINISCHE UNIVERSITAET WIEN3
TCURX3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT3
BIOSCI CONSULTING BVBA2
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
JANSSEN PHARMACEUTICA NV2
KING'S COLLEGE LONDON2
LEIDS UNIVERSITAIR MEDISCH CENTRUM2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MILTENYI BIOTEC BV & CO KG2
NOVARTIS PHARMA2
SANOFIAVENTIS2
THE UNIVERSITY OF MANCHESTER2
UNIVERSIDAD DE NAVARRA2
UNIVERSITA DEGLI STUDI DI MILANO2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAETSKLINIKUM JENA2
UNIVERSITY COLLEGE LONDON2
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH ZIEKENHUIS GRONINGEN1
AGENCE NATIONALE DE SECURITE DU MEDICAMENT ET DES PRODUITS DE SANTE1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AGENZIA ITALIANA DEL FARMACO1
ALLERGAN LIMITED1
ARTTIC1
ASOCIACION INSTITUTO BIODONOSTIA1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA1
AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY1
BAYER1
BERRY CONSULTANTS LLP1
BIOTALENTUM TUDASFEJLESZTO KFT1
BLUEBIRD BIO INC1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE1
CELGENE MANAGEMENT SARL1
CELL THERAPY CATAPULT LIMITED1
CENTRE DE REGULACIO GENOMICA1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHILDREN'S TUMOR FOUNDATION1
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER1
COVANCE LABORATORIES1
CUSTODIX NV1
DANMARKS TEKNISKE UNIVERSITET1
DEBRA AUSTRIA HILFE BEI EPIDERMOLYSIS BULLOSA1
DEUTSCHES ZENTRUM FUR LUFT UND RAUMFAHRT EV1
DOCUMENTAL OU1
DRKBLUTSPENDEDIENST BADENWURTTEMBERGHESSEN GGMBH1
DYNAMIC421
EATRIS ERIC1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERASMUS UNIVERSITEIT ROTTERDAM1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN HEMATOLOGY ASSOCIATION1
EUROSCAN INTERNATIONAL NETWORK EV1
F HOFFMANNLA ROCHE1
FAKULTNI NEMOCNICE U SV ANNY V BRNE1
FEDERAL AGENCY FOR MEDICINES AND HEALTH PRODUCTS1
FORUM DES PATIENTS EUROPEENS1
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA1
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU1
GERMAN STEMCELL NETWORK DEUTSCHES STAMMZELLNETZWERK EV1
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
HEALTH PRODUCTS REGULATORY AUTHORITY1
IMMETACYTE LIMITED1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INFARMED AUTORIDADE NACIONAL DO MEDICAMENTO E PRODUTOS DA SAUDE IP1
INSTITUT DE RECHERCHES SERVIER1
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE1
INSTITUT NATIONAL DU CANCER GIP1
INSTITUT PASTEUR1
JDRF INTERNATIONAL1
KAROLINSKA INSTITUTE1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN KNAW1
LAAKEALAN TURVALLISUUSJA KEHITTAMISKESKUS1
LAKEMEDELSVERKET1
LEIDEN UNIVERSITY1
LUND UNIVERSITY1
LUNDS UNIVERSITET1
MASARYKOVA UNIVERZITA1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY1
MEDIZINISCHE HOCHSCHULE HANNOVER1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MERCK SHARP & DOHME CORP1
MYELOMA PATIENTS EUROPE AISBL1
NATIONAL UNIVERSITY OF IRELAND GALWAY1

Constancy:

Total number of partners: 181
Partner loyalty:
Frequent Partner: (> 2 projects): 12
Rare Partner: 169
Frequent / Rare Partner Ratio: 0.07

Project overview:

Start dateProjectacronymrolefundingpartners
2021-03-01Training Network for Optimizing Adoptive T cell Therapy of Cancer T-OPparticipant4.100.95912
2021-02-01European consortium for communicating gene- and cell-based therapy information. EuroGCTparticipant1.999.78447
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18527
2020-03-01Training towards Personalized Antibiotic Treatment TIPATparticipant3.969.5837
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-01-01Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS) STARSparticipant1.986.00021
2018-01-01SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease CARAMBAparticipant6.097.87510